ISG15 and colorectal carcinoma: The difference observed in the Lm-LLO-ISG15 versus Control Lm in vivo, but not in the in vitro studies, indicates that ISG15 provides a therapeutic target and is important to elicit an anti-tumor response in syngeneic CRC mouse models.